TB prevention

TB prevention features

• 

  HIV and TB in Practice for nurses: Pregnancy and TB/HIV

  This article explains how to prevent and treat TB in pregnant women to protect both mother and child....

  From:  HIV & AIDS treatment in practice

• 

  HIV and TB in Practice for nurses: Drug-resistant TB

  This article summarises the key recommendations on the diagnosis and treatment of drug-resistant TB for nurses, and highlights examples of best practice in their care....

  From:  HIV & AIDS treatment in practice

• 

  HIV and TB in Practice for nurses: TB infection control

  This article provides practical information for nurses on TB infection control....

  From:  HIV & AIDS treatment in practice

• 

  HIV and TB in Practice for nurses: Starting ART for treatment and prevention in people with active TB and HIV

  This article provides information for nurses on starting HIV treatment for people with HIV and active TB....

  From:  HIV & AIDS treatment in practice

• 

  HIV and TB in Practice: Moving towards combination TB prevention

  This article looks at research on TB prevention, in particular the move towards combination TB prevention....

  From:  HIV & AIDS treatment in practice

• 

  HIV and TB in Practice for nurses: cotrimoxazole prophylaxis

  Cotrimoxazole prophylaxis is the use of a common antiobiotic to prevent a range of infections that commonly affect people living with HIV. ...

  From:  HIV & AIDS treatment in practice

• 

  HIV and TB in Practice for nurses: ART and TB prevention

  This edition is particularly intended for nurses and community health workers interested in TB and HIV....

  From:  HIV & AIDS treatment in practice

• 

  New laboratory tests to enhance TB diagnosis: Microscopy, LAM and Xpert MTB/RIF used as a drug resistance test

  The third in a series looking at the implications of new laboratory tests for TB diagnosis, particularly in people living with HIV. ...

  From:  HIV & AIDS treatment in practice

• 

  Strengthening TB laboratory capacity to support active case finding

  The role of new diagnostic tests for tuberculosis (TB) in supporting active case finding for TB....

  From:  HIV & AIDS treatment in practice

• 

  Diagnosing and preventing TB in children

  In the second part of this series, HATIP looks at diagnosing and preventing TB in children....

  From:  HIV & AIDS treatment in practice

TB prevention news from aidsmap

• Risk of recurrence of active TB is high for people with HIV

  People living with HIV who have a history of active tuberculosis (TB) have a significant risk of the recurrence of the disease, investigators report in the online edition of Clinical Infectious Diseases. The risk of developing active TB ...

  22 October 2012 | Michael Carter

• Taking isoniazid preventive therapy for one year reduces the risk of TB in people taking antiretroviral therapy

  Twelve months of isoniazid (INH) preventive therapy (IPT) significantly reduced the incidence of all TB diagnoses among HIV-positive people who were taking concurrent antiretroviral therapy (ART) according to results of a large randomised study presented as a late breaker study ...

  27 July 2012 | Theo Smart

• Thibela TB: Community-wide IPT did not improve TB control in South Africa’s mines at the population level

  Giving a six- to nine-month course of isoniazid preventive therapy (IPT) at a ‘community-wide level’ – to everyone working at randomly selected South African gold mines – had no effect on TB incidence, TB prevalence or all-cause mortality in ...

  15 March 2012 | Theo Smart

• Risk factors for development of TB after starting HIV therapy identified in North American research

  The development of tuberculosis (TB) after the initiation of antiretroviral therapy is associated with a low CD4 cell count, injecting drug use, and non-white race, investigators from the US and Canada report in the September 15th edition of the Journal ...

  25 August 2011 | Michael Carter

• New regimen prevents TB in 12 weekly doses

  A large trial has shown that a 12-week course of combination treatment for latent tuberculosis is just as effective as a nine-month course of isoniazid in countries with a low to moderate burden of TB, with the additional advantage ...

  17 May 2011 | Keith Alcorn

• TB still killing 4000 people with HIV each day, WHO reports

  Tuberculosis is still killing more than 4000 people with HIV every day worldwide, the World Health Organization reported this week. Despite progress over the past few years, more needs to be done to identify and treat HIV in ...

  12 November 2010 | Keith Alcorn

• Requiring tuberculin skin tests before implementing IPT leads to avoidable and substantial number of TB cases

  Delaying a course of isoniazid preventive therapy (IPT) to prevent active tuberculosis (TB) because a person with HIV hasn’t yet had a tuberculin skin test (TST), or received their results, leaves the individual at very high risk of developing ...

  20 July 2010 | Theo Smart

• Isoniazid preventive therapy doesn't increase risk of resistant TB

  Treatment with isoniazid preventive therapy does not lead to the development of drug-resistant tuberculosis, South African investigators report in the April 24th edition of AIDS. Drug susceptibility was monitored in gold miners who developed active tuberculosis ...

  13 April 2010 | Michael Carter

• More evidence supports isoniazid for TB prevention in people with HIV

  Two new studies presented this week at the 17th Conference on Retroviruses and Opportunistic Infections (CROI) in San Francisco add weight to a growing expert consensus that isoniazid preventive therapy (IPT) should be provided to people ...

  19 February 2010 | Keith Alcorn

More news

TB prevention news selected from other sources

• Tuberculosis prevention may speed drug resistance

  According to the new study, led by Harriet Mills at the University of Bristol, in communities that implement isoniazid preventive therapy (IPT), the incidence of new isoniazid-resistant cases per year will double in the next 40 years.

  15 April 2013 | Nature

• The Search for Swaziland’s TB-Infected Mine Workers

  “Mine workers come from the whole sub-region to our mines to catch TB and HIV and take it back to their families and communities,” South African Minister of Health Dr. Aaron Motsoaledi said.

  09 April 2013 | Inter Press Service

• Southern Africa cracks down on TB in mines

  South Africa's gold mines are estimated to have the highest number of new tuberculosis (TB) cases in the world, making the disease a leading export to neighbouring countries. IRIN takes a look at the declaration meant to change this situation.

  25 March 2013 | IRIN

• The historical arc of tuberculosis prevention

  It is somewhat ironic that just as the structural, social, and economic barriers to patient “non-compliance” are being taken seriously by the medical mainstream, the chief medical officer for England recently invoked a dystopian scenario of a drug-resistant bacterial rampage reminiscent of the early nineteenth century.

  24 March 2013 | Oxford University Press blog

• Virtual Issue: Tuberculosis

  Collected articles on the social history of tuberculosis and TB control policies.

  24 March 2013 | Social History of Medicine

• MISSOURI: Senate Passes Bill to Increase Tuberculosis Screenings and Penalize Spreading the Disease

  On February 14, the Missouri Senate voted unanimously to approve a bill requiring TB screening for more people and allow prosecution of those who spread the disease.

  21 February 2013 | CDC National Prevention Information Network

• Latent TB germs can hide in marrow cells, study says

  Scientists have found a hiding place in the body where bacteria that cause tuberculosis may take refuge — a clue that could one day help target treatments more effectively and surmount a major obstacle to eradicating the global epidemic.

  20 February 2013 | Boston Globe

• Revived search for a TB vaccine may be about to pay off

  After nearly 100 years, researchers could be on the verge of finding a vaccine that would eradicate tuberculosis infections, a scourge that kills 1.4 million people a year.

  04 February 2013 | Reuters

• 20 million lives saved through TB care and control

  An estimated 20 million people are alive today as a direct result of tuberculosis (TB) care and control, according to the WHO Global tuberculosis report 2012.

  17 October 2012 | WHO

• TB control – a “common responsibility”, says ECDC Director

  “We must embrace the concept of common responsibility between high burden and low burden countries, creating a platform for a truly global action against TB’, concluded the ECDC Director. ‘This is why I am particularly pleased that ECDC and the European Respiratory Society have developed 21 patient-centred standards that aim to guide clinicians and public health workers in their daily work to ensure optimal diagnosis, treatment and prevention of TB in the EU”.

  04 September 2012 | ECDC press release

More news